RELATED STUDY

Key Findings: 

Type of Study: 

Study Result:  Inconclusive

Research Location(s): 

Year of Pub: 


Cannabinoids Studied: 

Chemotype: 

Terpenes Studied: 

Receptors Studied: 

Ligands Studied: 

DOSING DETAILS   

Study Dosing Objective:  Effective Dose

Established Protocol:  Effective dose

Route of Administration: 

Cannabinoid Ratio:  (THC)   0    

Dosing Regimen:  THC at 0.18 mg/kg on a daily basis.

Titration:  Dose was increased for each subject to 0.32 mg/kg, over a period of ~2 weeks when responding was no longer affected by 0.18 mg/kg

Treatment Duration:  180 days

Clinical Relevance:  Δ9-THC shows the ability to prevent lymph node fibrosis, a serious irreversible consequence of HIV-induced chronic inflammation.




Citation: